Leqembi® Pen subcutaneous formulation approved in Japan
Go back to Leqembi® Pen subcutaneous formulation approved in Japan| BARNES GROUP, Inc. (NYSE: B) | Delayed: 43.88 +1.19 (2.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.69 | 52 Week High | $44.27 | |||
| Open | $42.68 | 52 Week Low | $30.07 | |||
| Day High | $44.18 | P/E | 33.50 | |||
| Day Low | $42.67 | EPS | $1.31 | |||
| Volume | 7,801,855 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 8.46 +0.37 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.09 | 52 Week High | $8.73 | |||
| Open | $8.20 | 52 Week Low | $2.86 | |||
| Day High | $8.53 | P/E | N/A | |||
| Day Low | $8.11 | EPS | $-3.82 | |||
| Volume | 1,067,366 | |||||
